MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases

References

• Lee, R. C., R. L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843–854
   PubMed Web of Science ®Google Scholar
• Wightman, B., I. Ha, and G. Ruvkun. 1993. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855–862
   PubMed Web of Science ®Google Scholar
• Winter, J., S. Jung, S. Keller, et al. 2009. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat. Cell. Biol. 11: 228–234
   PubMed Web of Science ®Google Scholar
• Shukla, G. C., J. Singh, and S. Barik. 2011. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol. 3: 83–92
   PubMedGoogle Scholar
• Bartel, D. P. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136: 215–233
   PubMed Web of Science ®Google Scholar
• Raisch, J., A. Darfeuille-Michaud, and H. T. Nguyen. 2013. Role of microRNAs in the immune system, inflammation and cancer. World J. Gastroenterol. 19: 2985–2996
   PubMed Web of Science ®Google Scholar
• Chen, S. L., M. H. Zheng, K. Q. Shi, et al. 2013. A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. BioDrugs 27: 25–34
   PubMed Web of Science ®Google Scholar
• Wijnen, W. J., Y. M. Pinto, and E. E. Creemers. 2013. The therapeutic potential of mirnas in cardiac fibrosis: where do we stand. J. Cardiovasc. Transl. Res. 6: 899–908
   PubMed Web of Science ®Google Scholar
• Vettori, S., S. Gay, O. Distler. 2012. Role of MicroRNAs in fibrosis. Open Rheumatol. J. 6: 130–139
   PubMedGoogle Scholar
• Kato, M., N. E. Castro, and R. Natarajan. 2013. MicroRNAs: potential mediators and biomarkers of diabetic complications. Free Radic. Biol. Med. 64: 85–94
   PubMed Web of Science ®Google Scholar
• Luo, X., K. Ranade, R. Talker, et al. 2013. microRNA-mediated regulation of innate immune response in rheumatic diseases. Arthritis Res. Ther. 15: 210 doi: 10.1186/ar4194
   PubMed Web of Science ®Google Scholar
• Reijerkerk, A., M. A. Lopez-Ramirez, B. van Het Hof, et al. 2013. MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis. J. Neurosci. 33: 6857–6863
   PubMed Web of Science ®Google Scholar
• Stenman, G., M. K. Andersson, and Y. Andrén. 2010. New tricks from an old oncogene. Cell Cycle 9: 2986–2995
   PubMed Web of Science ®Google Scholar
• He, Y., X. Jiang, and J. Chen. 2014. The role of miR-150 in normal and malignant hematopoiesis. Oncogene 33: 3887–3893
   PubMed Web of Science ®Google Scholar
• Zhou, B., S. Wang, C. Mayr, et al. 2007. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc. Natl. Acad. Sci. USA 104: 7080–7085
   PubMed Web of Science ®Google Scholar
• Hardy, R. R., and S. A. Shinton. 2004. Characterization of B lymphopoiesis in mouse bone marrow and spleen. Methods Mol. Biol. 271: 1–24
   PubMedGoogle Scholar
• Monticelli, S., K. M. Ansel, C. Xiao, et al. 2005. MicroRNA profiling of the murine hematopoietic system. Genome Biol. 6: R71
   PubMed Web of Science ®Google Scholar
• Spierings, D. C., D. McGoldrick, A. M. Hamilton-Easton, et al. 2011. Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage. Blood 117: 5340–5349
   PubMed Web of Science ®Google Scholar
• Bender, T. P., C. S. Kremer, M. Kraus, et al. 2004. Critical functions for c-Myb at three checkpoints during thymocyte development. Nat. Immunol. 5: 721–729
   PubMed Web of Science ®Google Scholar
• Thomas, M. D., C. S. Kremer, K. S. Ravichandran, et al. 2005. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23: 275–286
   PubMed Web of Science ®Google Scholar
• Xiao, C., D. P. Calado, G. Galler, et al. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146–159
   PubMed Web of Science ®Google Scholar
• Tan, L. P., M. Wang, J. L. Robertus, et al. 2009. miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes. Lab. Invest. 89: 708–716
   PubMed Web of Science ®Google Scholar
• Almanza, G., V. Anufreichik, J. J. Rodvold, et al. 2013. Synthesis and delivery of short, noncoding RNA by B lymphocytes. Proc. Natl. Acad. Sci. USA 110: 20182–20187
   PubMed Web of Science ®Google Scholar
• Almanza, G., A. Fernandez, S. Volinia, et al. 2010. Selected microRNAs define cell fate determination of murine central memory CD8 T cells. PLoS One 5: e11243
   PubMed Web of Science ®Google Scholar
• Wu, H., J. R. Neilson, P. Kumar, et al. 2007. miRNA profiling of naive, effector and memory CD8 T cells. PLoS One 2: e1020
   PubMed Web of Science ®Google Scholar
• Ghisi, M., A. Corradin, K. Basso, et al. 2011. Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150. Blood 117: 7053–7062
   PubMed Web of Science ®Google Scholar
• Kondo, M., I. L. Weissman, K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91: 661–672
   PubMed Web of Science ®Google Scholar
• Bezman, N. A., T. Chakraborty, T. Bender, and L. L. Lanier. 2011. miR-150 regulates the development of NK and iNKT cells. J. Exp. Med. 208: 2717–2731
   PubMed Web of Science ®Google Scholar
• Zheng, Q., L. Zhou, and Q. S. Mi. 2012. MicroRNA miR-150 is involved in Valpha14 invariant NKT cell development and function. J. Immunol. 188: 2118–2126
   PubMed Web of Science ®Google Scholar
• Fedeli, M., A. Napolitano, M. P. Wong, et al. 2009. Dicer-dependent microRNA pathway controls invariant NKT cell development. J. Immunol. 183: 2506–2512
   PubMed Web of Science ®Google Scholar
• Kim, N., M. Kim, S. Yun, et al. 2014. MicroRNA-150 regulates the cytotoxicity of natural killers by targeting perforin-1. J. Allergy. Clin. Immunol. 134: 195–203
   PubMed Web of Science ®Google Scholar
• Schmidt, W. M., A. O. Spiel, B. Jilma, et al. 2009. In vivo profile of the human leukocyte microRNA response to endotoxemia. Biochem. Biophys. Res. Commun. 380: 437–441
   PubMed Web of Science ®Google Scholar
• El-Assaad, F., C. Hempel, V. Combes, et al. 2011. Differential microRNA expression in experimental cerebral and noncerebral malaria. Infect. Immun. 79: 2379–2384
   PubMed Web of Science ®Google Scholar
• Wang, X., L. Ye, W. Hou, et al. 2009. Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113: 671–674
   PubMed Web of Science ®Google Scholar
• Mantri, C. K., J. V. Mantri, J. Pandhare, and C. Dash. 2014. Methamphetamine inhibits HIV-1 replication in CD4(+) T cells by modulating anti-HIV-1 miRNA expression. Am. J. Pathol. 184: 92–100
   PubMed Web of Science ®Google Scholar
• Chiang, K., T. L. Sung, and A. P. Rice. 2012. Regulation of cyclin T1 and HIV-1 replication by microRNAs in resting CD4+ T lymphocytes. J. Virol. 86: 3244–3252
   PubMed Web of Science ®Google Scholar
• Zhou, H., S. A. Hasni, P. Perez, et al. 2013. miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J. Am. Soc. Nephrol. 24: 1073–1087
   PubMed Web of Science ®Google Scholar
• Bayry, J., and T. R. Radstake. 2013. Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies. Expert Rev. Clin. Immunol. 9: 297–299
   PubMed Web of Science ®Google Scholar
• Lakner, A. M., N. M. Steuerwald, T. L. Walling, et al. 2012. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 56: 300–310
   PubMed Web of Science ®Google Scholar
• Gebauer, N., V. Bernard, W. Gebauer, et al. 2013. MicroRNA expression and JAK2 allele burden in bone marrow trephine biopsies of polycythemia vera, essential thrombocythemia and early primary myelofibrosis. Acta Haematol. 129: 251–256
   PubMed Web of Science ®Google Scholar
• Wang, B., R. Komers, R. Carew, and C. E. Winbanks. 2012. Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis. J. Am. Soc. Nephrol. 23: 252–265
   PubMed Web of Science ®Google Scholar
• Pfender, N., and R. Martin. 2014. Daclizumab (anti-CD25) in multiple sclerosis. Exp. Neurol. 262: 44–51
   PubMed Web of Science ®Google Scholar
• Fenoglio, C., C. Cantoni, M. De Riz, et al. 2011. Expression and genetic analysis of miRNAs involved in CD4+ cell activation in patients with multiple sclerosis. Neurosci. Lett. 504: 9–12
   PubMed Web of Science ®Google Scholar
• Martinelli-Boneschi, F., C. Fenoglio, P. Brambilla, et al. 2012. MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci. Lett. 508: 4–8
   PubMed Web of Science ®Google Scholar
• Dai, Y., W. Sui, H. Lan, et al. 2009. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol. Int. 29: 749–754
   PubMed Web of Science ®Google Scholar
• Zhong, S., S. Zhang, E. Bair, et al. 2012. Differential expression of microRNAs in normal and inflamed human pulps. J. Endod. 38: 746–752
   PubMed Web of Science ®Google Scholar
• Wang, X., L. Ye, Y. Zhou, et al. 2011. Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes. Am. J. Pathol. 178: 41–47
   PubMed Web of Science ®Google Scholar
• Munshi, S. U., H. Panda, P. Holla, et al. 2014. MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy. PLoS One 9: e95920
   PubMed Web of Science ®Google Scholar
• Siliciano, J. D., J. Kajdas, D. Finzi, et al. 2003. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9: 727–728
   PubMed Web of Science ®Google Scholar
• Huang, J., F. Wang, E. Argyris, et al. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13: 1241–1247
   PubMed Web of Science ®Google Scholar
• Zhou, Y., X. Wang, M. Liu, et al. 2010. A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology 131: 40–49
   PubMed Web of Science ®Google Scholar
• Jiménez, V. C., T. Booiman, S. W. de Taeye, et al. 2012. Differential expression of HIV-1 interfering factors in monocyte-derived macrophages stimulated with polarizing cytokines or interferons. Sci. Rep. 2: 763
   PubMed Web of Science ®Google Scholar
• He, T., G. Feng, H. Chen, et al. 2009. Identification of host encoded microRNAs interacting with novel swine-origin influenza A (H1N1) virus and swine influenza virus. Bioinformation 4: 112–118
   PubMedGoogle Scholar
• Chen, Y., L. Li, Z. Zhou, et al. 2012. A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection. Med. Microbiol. Immunol. 201: 389–395
   PubMed Web of Science ®Google Scholar
• Niimoto, T., T. Nakasa, M. Ishikawa, et al. 2010. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet. Disord. 11: 209
   PubMed Web of Science ®Google Scholar
• Venugopal, S. K., J. Jiang, T. H. Kim, et al. 2010. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 298: G101–G106
   PubMed Web of Science ®Google Scholar
• Honda, N., M. Jinnin, T. Kira-Etoh, et al. 2013. miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin beta3. Am. J. Pathol. 182: 206–216
   PubMed Web of Science ®Google Scholar
• Jernas, M., C. Malmestrom, M. Axelsson, et al. 2013. MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS). BMC Immunol. 14: 32
   PubMed Web of Science ®Google Scholar
• Lu, M. C., N. S. Lai, H. C. Chen, et al. 2013. Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis. Clin. Exp. Immunol. 171: 91–99
   PubMed Web of Science ®Google Scholar
• Bryniarski, K., W. Ptak, A. Jayakumar, et al. 2013. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J. Allergy Clin. Immunol. 132: 170–181
   PubMed Web of Science ®Google Scholar
• Cusick, M. F., J. E. Libbey, and R. S. Fujinami. 2012. Molecular mimicry as a mechanism of autoimmune disease. Clin. Rev. Allergy Immunol. 42: 102–111
   PubMed Web of Science ®Google Scholar
• Benoist, C., and D. Mathis. 2001. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat. Immunol. 2: 797–801
   PubMed Web of Science ®Google Scholar
• Christen, U., E. Hintermann, M. Holdener, and M. G. von Herrath. 2010. Viral triggers for autoimmunity: is the ‘glass of molecular mimicry’ half full or half empty? J. Autoimmun. 34: 38–44
   PubMed Web of Science ®Google Scholar
• Carugati, M., M. Franzetti, A. Torre, et al. 2013. Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature. Clin. Rheumatol. 32: 1399–1405
   Google Scholar
• Hazarika, I., B. P. Chakravarty, S. Dutta, and N. Mahanta. 2006. Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treat ment with IVcyclophosphamide. Clin. Rheumatol. 25: 98–100
   PubMed Web of Science ®Google Scholar
• Nguyen, B. Y., and J. D. Reveille. 2009. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Curr. Opin. Rheumatol. 21: 404–410
   PubMed Web of Science ®Google Scholar
• Tarr, G., M. Makda, E. Musenge, and M. Tikly. 2014. Effect of human immunodeficiency virus infection on disease activity in rheumatoid arthritis: a retrospective study in South Africans. J. Rheumatol. 41: 1645–1649
   PubMed Web of Science ®Google Scholar
• Gold, J., R. Goldacre, H. Maruszak, et al. 2015. HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study. J. Neurol. Neurosurg. Psychiatry 86: 9–12
   PubMed Web of Science ®Google Scholar
• Cusick, M. F., J. E. Libbey, and R. S. Fujinami. 2013. Multiple sclerosis: autoimmunity and viruses. Curr. Opin. Rheumatol. 25: 496–501
   PubMed Web of Science ®Google Scholar